rfhg_213806.1

Basic information about the TSS

---

TSS ID: rfhg_213806.1 Species: human Chr: chr19		Start: 46602168 End: 46602176 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3067440,EH38E1958437)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK295927:-17 GeneID: 808 HGNC/MGI_ID: HGNC:1449 UniProt_ID: Nearer transcript ids and distances: ENST00000596362.1:-96 NM_001329922.1:-96 ENST00000599839.5:-99 NM_001329923.1:-99 AK310762:-99 view more...

Gene_name: calmodulin 3 Gene_symbol: CALM3 Gene_synonyms: PHKD PHKD3 Gene_source: HGNC:1449

TATA-Box annotation

---

Distance to TSS:	100
Nearest PromoterID:	NM_001329922
Entrez ID:	808
Nearest Unigene:	Hs.515487
Nearest Refseq:	NM_005184
Nearest Ensembl:	ENSG00000160014
Gene Name:	calmodulin 3
Gene Alias:	CALM|CAM1|CAM2|CAMB|CaM|CaMIII|HEL-S-72|PHKD|PHKD3
Gene Type:	protein-coding
CpG%:	0.125000
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p3@CALM3 p4@CALM3 p8@CALM3 p10@CALM3
Sample		p3@CALM3	p4@CALM3	p8@CALM3	p10@CALM3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	134.80	24.55	1.95	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	135.35	24.08	1.62	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	131.17	21.41	2.51	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	104.99	19.96	0.83	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	117.88	17.77	1.12	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	112.99	16.86	2.13	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	126.15	26.15	1.96	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	122.81	18.89	1.21	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	119.25	23.08	1.07	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	96.80	13.33	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	90.95	12.53	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	79.68	10.57	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	72.21	20.31	1.93	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	70.36	17.14	2.10	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	70.26	17.34	2.42	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	69.41	14.33	6.04	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	67.27	13.32	5.02	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	67.91	9.28	4.22	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	54.38	9.06	4.27	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	64.54	19.56	4.21	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	65.89	16.31	3.74	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	72.16	17.43	3.11	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	74.71	14.35	2.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	68.92	16.26	3.40	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	60.37	13.93	2.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	62.99	13.93	3.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	61.54	6.59	3.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	74.26	21.22	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	63.16	14.70	2.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	75.28	15.20	3.62	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	66.57	13.82	6.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	61.74	13.87	2.54	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	61.41	10.97	4.01	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	75.71	11.55	3.46	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	67.13	18.32	3.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	71.67	21.27	3.26	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	71.33	21.66	3.68	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	64.27	14.91	1.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	79.14	14.86	5.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	69.86	14.88	2.88	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	63.52	19.76	3.76	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	65.29	10.83	4.54	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	61.58	18.56	4.01	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	63.29	16.61	2.62	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	74.69	20.88	3.41	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	77.47	13.96	6.75	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	67.17	17.99	3.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	66.76	22.35	2.68	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	66.79	20.83	5.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	62.07	11.32	3.24	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	73.99	15.37	3.07	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	76.94	17.57	4.67	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	55.97	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	71.68	10.65	2.13	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	72.57	12.92	2.65	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	76.34	12.58	9.23	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	62.00	11.48	7.35	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	60.28	14.58	3.24	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	66.80	18.63	1.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	63.81	16.97	5.66	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	77.56	14.10	2.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	55.52	15.14	2.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	73.25	8.76	7.96	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	59.46	16.65	5.44	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	70.83	18.85	3.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	85.55	23.43	3.19	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	260.62	55.28	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	107.25	14.14	3.41	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	99.67	20.33	2.98	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	82.56	21.11	1.41	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	91.74	15.57	3.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	101.46	19.80	4.95	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	103.04	22.01	1.53	0.00
Adipocyte - breast, donor1	11376-118A8	110.24	34.21	1.58	0.63
Adipocyte - breast, donor2	11327-117E4	82.94	34.49	0.64	0.80
Adipocyte - omental, donor1	11473-119C6	78.63	17.05	0.13	0.76
Adipocyte - omental, donor2	11474-119C7	121.09	42.61	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	68.99	32.82	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	126.96	28.07	2.55	3.83
Adipocyte - subcutaneous, donor1	11259-116F8	45.08	25.29	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	65.94	41.10	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	41.01	45.18	0.17	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	112.65	71.38	0.59	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	78.24	34.49	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	81.96	59.94	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	75.24	38.21	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	52.28	46.65	0.40	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	87.14	41.96	1.61	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	63.98	31.46	0.00	2.67
Adipocyte differentiation, day08, donor4	13029-139E5	46.74	20.03	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	51.57	48.66	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	73.84	42.45	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	67.74	30.11	0.33	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	39.28	25.88	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	157.13	72.93	1.10	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	185.03	115.46	2.15	3.23
Alveolar Epithelial Cells, donor3	11671-122G6	93.45	31.15	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	78.80	27.71	0.18	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	90.37	33.47	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	92.04	34.31	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	179.99	49.32	0.46	0.69
Anulus Pulposus Cell, donor2	11463-119B5	139.11	88.41	0.24	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	84.47	43.58	0.90	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	77.28	40.81	0.87	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	77.05	12.84	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	89.68	43.04	0.30	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	86.00	37.94	3.79	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	87.13	24.42	1.98	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	86.42	31.84	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	80.58	46.12	1.46	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	83.14	13.66	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	88.89	39.17	0.75	3.01
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	78.37	39.91	0.00	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	90.27	31.34	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	109.71	36.41	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	70.97	50.50	4.09	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	87.01	30.31	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	84.12	33.75	0.54	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	99.95	43.27	1.51	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	98.63	23.52	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	99.50	38.04	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	98.52	39.81	0.33	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	92.46	18.01	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	95.58	31.86	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	89.02	41.17	0.17	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	79.70	20.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	77.18	34.47	0.00	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	116.11	43.26	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	94.49	20.59	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	84.37	46.74	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	104.32	41.26	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	91.88	28.39	0.77	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	82.11	43.64	0.47	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	97.75	45.02	0.32	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	93.46	29.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	67.85	31.00	0.58	3.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	105.38	42.45	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	99.79	29.70	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	77.30	41.19	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	101.37	39.73	0.76	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	85.14	36.22	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	84.58	49.19	0.43	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	95.26	43.40	1.06	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	89.02	22.91	0.87	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	107.70	41.57	2.83	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	96.97	44.59	0.51	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	76.44	25.48	2.32	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	78.17	50.70	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	94.77	39.88	0.64	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	84.83	21.66	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	80.92	40.82	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	110.34	47.82	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	114.76	20.40	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	79.07	25.93	0.00	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	110.45	38.19	0.41	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	79.25	34.58	0.61	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	77.92	41.59	0.00	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	95.79	41.91	0.22	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	91.55	15.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	70.34	38.22	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	97.18	38.13	0.26	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	82.87	24.71	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	338.48	127.11	2.46	0.25
Astrocyte - cerebellum, donor2	11580-120F5	241.34	154.04	0.86	1.03
Astrocyte - cerebellum, donor3	11661-122F5	168.85	40.06	0.84	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	191.72	65.19	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	184.26	65.03	1.46	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	200.47	79.80	0.30	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	382.71	130.51	0.92	1.95
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	379.60	119.39	0.00	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	362.78	114.93	0.57	0.68
Basophils, donor1	12241-129G9	80.81	43.15	0.26	0.78
Basophils, donor2	12242-129H1	102.47	37.52	0.00	0.36
Basophils, donor3	12243-129H2	76.88	64.83	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	76.97	33.20	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	146.30	95.55	0.91	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	93.52	58.37	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	116.24	86.09	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	60.57	38.00	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	38.15	18.71	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	182.10	34.11	1.55	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	127.86	24.92	1.40	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	160.21	31.02	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	41.37	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	49.59	25.92	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	60.51	27.10	0.19	0.93
CD14+ Monocytes, donor3	11381-118B4	64.32	41.27	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	414.66	108.97	0.85	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	413.57	107.28	0.76	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	395.80	106.18	1.64	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	55.22	29.92	0.43	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	55.22	22.03	0.91	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	62.30	29.37	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	47.54	18.58	0.17	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	39.47	17.94	0.83	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	45.87	18.35	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	43.66	20.56	0.20	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	45.22	23.86	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	58.11	26.55	0.87	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	39.10	16.39	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	53.86	19.54	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	44.37	29.95	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	52.36	21.42	0.30	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	40.71	20.95	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	45.39	16.03	0.42	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	42.55	21.51	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	47.05	13.80	0.45	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	41.90	18.33	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	50.57	24.75	0.81	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	58.44	29.83	0.35	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	66.91	30.30	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	42.62	19.11	0.55	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	31.35	17.26	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	40.36	17.11	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	35.92	25.98	0.52	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	46.46	27.13	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	69.41	28.02	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	49.14	23.34	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	36.16	10.20	0.23	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	32.94	16.24	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	58.63	34.87	0.65	1.53
CD14+CD16+ Monocytes, donor2	11801-124D1	67.68	48.51	0.46	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	61.30	47.66	0.65	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	70.39	39.55	0.78	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	61.82	38.95	0.35	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	73.80	46.15	0.22	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	52.31	36.49	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	57.75	46.11	0.44	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	63.80	53.48	0.84	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	79.26	44.71	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	72.54	33.90	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	63.17	35.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	58.10	24.52	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	71.83	36.99	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	78.62	40.71	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	76.87	48.63	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	75.14	38.23	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	69.04	29.59	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	52.96	20.31	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	71.18	17.16	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	391.53	132.13	0.00	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	313.60	125.04	0.40	1.20
CD34+ Progenitors, donor1	11545-120B6	78.32	13.05	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	55.06	19.66	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	201.78	45.09	1.50	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	203.61	38.56	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	186.03	55.70	1.07	0.36
CD4+ T Cells, donor2	11306-117C1	104.71	45.31	1.22	0.61
CD4+ T Cells, donor3	11382-118B5	131.45	53.07	0.61	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	215.42	59.47	1.02	3.06
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	261.66	70.30	0.45	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	267.63	67.84	1.72	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	145.07	47.41	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	186.12	73.74	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	217.55	62.63	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	263.16	43.07	0.87	2.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	302.83	72.36	2.03	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	266.31	64.16	0.81	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	151.97	35.42	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	203.69	67.78	1.75	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	221.75	51.92	1.32	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	343.64	32.89	1.26	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	450.86	88.72	1.66	3.12
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	357.52	51.46	0.67	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	266.77	53.30	0.54	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	279.23	71.82	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	319.19	68.14	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	265.53	48.03	0.37	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	265.36	68.88	1.30	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	256.81	80.70	0.42	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	118.31	42.47	1.01	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	120.44	60.22	0.43	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	179.56	54.04	1.31	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	244.96	88.09	0.00	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	161.56	72.01	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	163.31	85.15	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	206.03	94.71	0.55	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	254.47	123.19	0.74	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	201.74	52.36	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	253.19	80.22	0.72	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	249.30	80.33	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	103.78	39.29	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	94.98	34.54	0.38	0.75
CD8+ T Cells, donor3	11383-118B6	145.94	63.37	0.50	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	107.36	27.76	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	104.48	20.61	0.72	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	97.12	17.78	0.55	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	114.98	16.21	0.60	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	117.35	28.32	0.24	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	118.92	22.51	1.59	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	136.02	22.81	1.09	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	135.29	18.69	1.05	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	132.27	23.69	1.41	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	166.33	21.74	1.81	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	142.64	17.72	1.74	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	175.58	27.18	2.13	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	130.89	16.63	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	138.45	16.85	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	116.36	17.90	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	124.61	25.57	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	115.95	24.17	0.00	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	108.89	18.62	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	139.44	25.99	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	129.79	23.37	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	134.65	22.44	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	135.01	19.51	2.29	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	138.33	22.07	0.39	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	118.00	15.88	3.03	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	80.30	17.67	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	78.34	10.49	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	125.22	20.04	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	122.46	25.59	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	117.10	49.90	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	119.97	52.20	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	176.11	50.27	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	120.12	29.50	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	111.39	23.10	0.23	1.02
Chondrocyte - re diff, donor2	11339-117F7	224.71	25.07	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	126.17	26.69	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	180.63	51.87	0.92	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	125.05	45.32	1.71	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	135.84	51.77	0.71	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	498.58	98.67	0.55	1.28
Corneal Epithelial Cells, donor1	11526-119I5	124.50	69.82	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	112.62	36.40	3.41	1.14
Corneal Epithelial Cells, donor3	11687-122I4	135.74	71.58	1.02	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	71.49	23.11	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	66.24	21.13	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	82.50	27.32	0.32	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	28.36	16.74	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	30.03	16.32	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	24.68	26.62	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	130.41	62.54	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	144.93	65.13	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	156.67	78.33	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	184.01	55.83	0.39	1.18
Endothelial Cells - Artery, donor1	11264-116G4	118.09	61.67	0.29	0.87
Endothelial Cells - Artery, donor2	11341-117F9	97.64	43.06	1.18	0.71
Endothelial Cells - Artery, donor3	11413-118E9	115.70	88.71	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	82.45	57.41	1.11	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	102.54	64.20	1.22	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	81.47	48.77	0.85	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	97.76	63.29	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	86.95	40.09	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	84.93	57.42	0.14	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	133.24	76.02	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	78.09	38.79	0.00	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	192.08	109.21	1.86	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	149.26	132.75	1.74	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	141.79	128.23	2.56	0.73
Endothelial Cells - Vein, donor1	11267-116G7	150.15	75.08	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	123.63	74.04	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	152.92	96.72	0.31	0.63
Eosinophils, donor1	12244-129H3	274.44	45.74	0.00	0.00
Eosinophils, donor2	12245-129H4	158.43	163.38	3.30	0.00
Eosinophils, donor3	12246-129H5	160.51	167.64	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	91.13	40.31	1.22	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	35.36	20.80	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	130.13	28.74	1.64	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	92.08	23.76	1.97	1.97
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	155.36	45.61	1.30	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	185.19	54.21	0.85	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	73.97	23.75	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	154.72	37.65	0.95	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	67.45	16.07	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	202.64	78.07	1.66	1.99
Fibroblast - Cardiac, donor1	11268-116G8	134.73	49.90	0.45	1.81
Fibroblast - Cardiac, donor2	11345-117G4	152.35	60.64	0.00	2.27
Fibroblast - Cardiac, donor3	11417-118F4	75.39	33.75	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	124.88	62.44	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	109.65	65.10	0.25	0.63
Fibroblast - Cardiac, donor6	11460-119B2	120.97	74.28	0.76	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	180.62	78.65	1.21	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	88.01	37.53	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	104.00	58.59	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	152.22	89.72	0.23	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	155.19	60.89	0.17	1.19
Fibroblast - Dermal, donor1	11269-116G9	74.19	49.77	0.47	0.94
Fibroblast - Dermal, donor2	11346-117G5	151.88	69.34	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	104.81	50.41	0.60	0.60
Fibroblast - Dermal, donor4	11450-119A1	108.75	77.44	1.02	1.58
Fibroblast - Dermal, donor5	11454-119A5	121.59	77.28	0.87	1.40
Fibroblast - Dermal, donor6	11458-119A9	149.10	95.18	1.62	1.30
Fibroblast - Gingival, donor1	11237-116D4	127.23	52.47	1.25	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	187.85	39.82	2.10	0.52
Fibroblast - Gingival, donor2	11318-117D4	139.82	67.61	1.32	1.32
Fibroblast - Gingival, donor3	11394-118C8	100.26	51.53	0.58	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	115.32	37.40	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	61.67	21.67	0.00	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	238.52	64.54	1.25	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	153.35	32.45	0.54	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	317.94	79.75	0.71	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	194.07	48.26	1.46	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	176.85	45.00	0.82	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	161.36	53.75	0.55	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	96.11	17.76	0.59	0.29
Fibroblast - Lung, donor1	11270-116H1	100.59	29.91	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	110.42	50.73	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	124.09	54.66	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	406.51	150.78	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	131.47	58.74	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	140.22	50.94	0.56	0.28
Fibroblast - Mammary, donor1	11540-120B1	252.92	147.37	0.41	0.81
Fibroblast - Mammary, donor2	11620-122A9	211.69	99.86	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	142.95	77.43	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	164.30	77.01	1.36	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	168.82	95.10	1.37	1.97
Fibroblast - Periodontal Ligament, donor3	11395-118C9	145.96	58.44	0.92	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	135.48	53.43	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	126.90	32.94	0.27	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	81.41	34.33	0.12	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	136.40	64.11	0.22	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	233.87	67.66	1.42	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	217.83	106.24	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	147.87	68.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	103.39	26.39	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	123.62	26.82	1.07	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	184.67	38.23	1.38	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	79.73	24.97	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	219.90	65.96	0.97	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	83.26	16.45	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	170.81	39.54	0.98	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	81.61	22.86	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	217.80	67.21	0.90	1.61
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	118.48	31.73	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	167.43	35.46	1.24	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	185.99	52.99	1.54	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	81.12	20.69	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	239.57	78.93	1.07	1.81
Fibroblast - skin walker warburg, donor1	11554-120C6	230.59	68.15	0.51	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	156.66	32.62	2.35	2.35
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	775.59	221.60	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	52.29	37.48	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	74.54	17.68	0.00	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	113.20	38.52	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	102.97	41.65	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	222.01	55.89	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	174.83	52.32	1.91	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	211.10	99.84	1.71	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	290.92	105.34	3.31	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	283.58	86.31	3.42	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	210.02	93.32	1.78	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	275.44	117.63	2.91	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	288.64	99.15	1.96	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	153.45	67.22	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	180.19	55.54	0.85	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	171.91	53.57	0.49	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	169.23	46.47	0.81	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	156.97	67.15	0.62	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	151.16	62.98	0.69	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	143.33	37.20	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	200.57	58.64	0.46	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	139.26	59.92	0.62	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	135.74	73.44	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	233.43	61.16	1.18	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	168.34	57.38	0.64	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	185.66	61.89	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	231.68	54.44	1.81	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	187.96	58.02	1.02	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	235.25	52.14	0.44	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	375.54	72.53	0.42	1.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	384.25	72.92	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	189.55	57.65	0.11	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	234.36	51.00	0.50	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	247.67	54.31	1.23	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	229.82	49.31	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	204.76	56.38	0.58	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	181.94	46.03	0.67	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	236.74	50.26	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	191.50	52.27	1.23	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	188.19	45.55	0.32	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	215.84	31.43	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	171.98	57.33	0.57	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	185.70	55.52	0.16	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	207.08	41.36	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	164.54	49.76	0.84	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	188.60	41.28	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	199.19	37.03	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	126.57	46.66	0.19	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	143.60	36.63	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	134.49	40.09	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	112.96	44.43	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	184.87	52.86	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	156.15	39.82	0.55	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	170.63	31.14	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	293.56	58.51	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	157.24	30.87	0.26	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	146.07	34.50	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	389.88	62.78	0.51	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	259.38	85.40	0.40	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	145.29	49.15	0.62	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	221.15	67.31	0.20	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	217.49	80.42	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	216.72	66.40	1.13	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	231.52	81.17	1.38	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	217.78	74.24	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	264.58	72.72	0.39	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	215.00	64.18	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	248.65	93.90	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	231.09	88.86	0.65	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	212.08	70.42	1.24	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	246.59	83.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	232.67	83.89	1.12	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	245.46	82.69	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	235.71	87.24	1.68	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	243.01	91.29	2.23	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	240.14	83.90	0.68	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	215.08	83.53	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	251.42	88.77	1.15	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	215.77	84.36	0.89	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	176.19	98.26	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	261.78	83.26	0.83	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	249.46	67.89	1.84	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	179.13	142.25	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	210.66	65.73	3.08	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	197.54	67.15	0.65	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	187.28	98.99	0.67	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	221.91	71.66	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	212.94	59.57	1.37	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	159.03	67.09	12.42	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	195.35	67.47	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	167.77	63.97	0.00	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	258.92	69.69	0.00	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	215.77	69.80	0.40	3.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	197.34	61.18	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	226.64	59.02	1.18	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	219.96	69.43	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	179.50	49.15	2.19	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	160.21	41.54	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	202.35	62.68	0.60	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	180.51	47.07	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	71.90	49.08	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	92.31	46.57	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	157.42	55.10	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	73.26	31.08	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	91.90	32.17	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	69.86	19.50	0.35	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	74.61	19.58	0.34	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	64.16	18.66	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	61.21	19.13	0.11	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	76.29	18.91	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	62.86	18.08	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	64.26	21.17	0.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	69.82	17.50	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	59.27	16.02	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	171.80	156.13	1.68	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	144.12	73.14	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	108.40	39.66	2.64	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	194.35	88.53	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	196.16	59.57	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	105.43	51.58	0.52	0.35
Hepatocyte, donor1	11523-119I2	104.11	27.84	2.42	0.00
Hepatocyte, donor2	11603-120I1	62.49	17.24	1.08	0.00
Hepatocyte, donor3	11684-122I1	94.48	41.11	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	222.57	35.25	2.61	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	424.54	43.00	1.75	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	105.37	63.12	0.00	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	92.33	31.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	40.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	89.98	33.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	87.59	12.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	261.10	23.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	89.70	35.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	105.13	9.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	100.71	34.11	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	85.03	20.01	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	79.87	14.52	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	104.55	17.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	78.71	34.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	26.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	72.43	22.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	74.24	40.21	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	29.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	83.98	21.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	115.91	25.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	88.82	35.04	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	105.79	29.81	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	80.37	20.90	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	85.87	35.08	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	92.05	24.55	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	81.63	22.67	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	44.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	103.31	26.90	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	105.45	26.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	89.91	19.77	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	98.42	29.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	91.40	20.71	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	69.68	39.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	90.75	24.08	0.00	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	70.24	29.85	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	81.72	25.15	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	84.14	28.51	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	104.02	48.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	106.99	19.45	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	102.89	23.54	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	85.49	47.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	87.11	38.33	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	75.74	23.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	85.90	20.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	76.94	42.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	81.00	22.09	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	78.66	33.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	37.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	66.61	26.43	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	92.29	22.68	0.00	0.57
Keratinocyte - epidermal, donor2	11349-117G8	59.15	26.94	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	68.91	44.11	0.09	0.38
Keratinocyte - oral, donor1	11251-116E9	110.34	38.94	0.34	0.34
Keratocytes, donor1	11527-119I6	161.94	83.89	0.34	1.03
Keratocytes, donor2	11607-120I5	194.52	101.95	1.17	0.00
Keratocytes, donor3	11688-122I5	60.86	26.68	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	151.66	76.93	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	85.22	37.76	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	184.88	58.47	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	88.40	40.06	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	112.29	51.34	0.12	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	68.37	18.42	0.84	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	91.46	42.19	0.47	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	82.81	36.56	0.00	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	72.17	18.28	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	80.21	43.02	0.11	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	64.02	31.19	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	74.58	17.44	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	92.05	41.10	0.56	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	61.31	20.96	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	70.38	21.71	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	90.35	39.99	0.37	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	77.35	37.28	0.35	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	67.50	19.80	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	82.00	37.50	0.55	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	72.37	28.64	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	68.58	18.39	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	83.81	42.82	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	82.61	40.48	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	65.02	16.99	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	89.12	40.08	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	65.47	32.98	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	74.86	17.77	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	86.13	43.29	0.15	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	66.36	28.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	66.38	20.94	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	85.86	41.20	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	63.97	24.76	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	72.25	15.62	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	87.26	37.00	0.53	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	63.00	30.53	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	56.23	13.23	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	83.38	41.13	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	68.12	38.50	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	58.81	15.57	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	84.97	37.81	0.14	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	67.54	29.59	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	73.65	16.43	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	83.28	39.33	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	69.33	30.22	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	60.11	12.12	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	92.43	37.50	0.16	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	78.78	36.17	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	64.35	14.70	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	81.22	34.37	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	96.90	41.70	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	69.92	16.39	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	84.14	43.26	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	135.96	20.39	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	143.45	46.80	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	109.85	25.24	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	134.13	21.58	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	148.40	41.50	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	117.68	31.75	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	130.88	23.19	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	132.03	32.12	4.76	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	135.72	30.99	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	127.09	24.72	0.58	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	117.95	28.36	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	148.76	32.52	0.68	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	146.87	26.70	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	136.91	35.64	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	111.27	19.32	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	128.87	23.94	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	136.60	36.02	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	151.16	30.23	1.32	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	124.55	29.45	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	150.04	38.32	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	147.23	30.40	1.25	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	144.61	27.75	1.12	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	149.40	41.21	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	150.09	31.06	1.74	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	127.34	25.41	0.00	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	134.44	29.88	1.66	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	164.02	32.87	0.71	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	136.82	22.13	0.74	4.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	125.49	17.27	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	142.37	34.54	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	119.45	15.29	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	143.58	33.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	141.44	30.73	0.45	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	140.76	23.70	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	151.62	38.09	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	148.64	30.10	1.49	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	126.21	20.68	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	137.01	37.68	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	147.60	32.65	0.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	120.06	25.34	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	127.27	33.42	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	143.33	31.28	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	132.58	18.25	0.00	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	124.57	30.30	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	141.50	30.74	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	133.74	23.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	141.74	32.79	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	148.06	39.21	0.80	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	145.37	21.08	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	151.77	34.49	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	150.45	33.54	1.48	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	133.61	6.59	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	146.32	36.71	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	136.99	30.19	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	132.52	29.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	152.75	44.53	0.89	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	132.56	30.89	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	144.48	19.79	0.66	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	134.92	40.48	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	144.83	35.44	0.44	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	135.30	23.48	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	135.58	38.86	0.44	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	138.47	31.63	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	125.58	17.72	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	136.50	36.53	0.96	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	133.58	35.78	0.40	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	126.39	20.05	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	92.00	23.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	130.72	28.12	0.38	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	150.28	20.66	2.07	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	102.19	33.86	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	156.23	32.01	0.95	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	126.88	18.66	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	104.59	24.14	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	169.18	29.83	2.06	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	140.76	21.93	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	120.31	32.35	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	152.27	39.11	1.66	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	154.26	18.01	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	117.75	30.48	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	150.54	31.60	0.46	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	138.49	17.40	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	116.02	41.17	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	135.37	27.88	1.62	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	126.65	23.86	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	114.70	32.01	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	157.28	35.90	1.14	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	132.67	16.87	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	124.76	32.83	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	141.21	28.95	0.45	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	147.39	30.41	0.52	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	123.34	27.19	2.65	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	172.52	35.34	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	338.91	109.40	0.68	1.14
Macrophage - monocyte derived, donor2	11313-117C8	356.55	79.64	0.37	2.02
Macrophage - monocyte derived, donor3	11389-118C3	316.69	102.37	0.79	1.97
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	85.49	19.65	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	71.30	13.47	0.16	0.79
Mallassez-derived cells, donor3	11930-125I4	110.08	32.94	0.42	0.42
Mammary Epithelial Cell, donor1	11273-116H4	98.45	26.41	0.30	0.50
Mammary Epithelial Cell, donor2	11350-117G9	86.58	31.85	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	92.54	43.40	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	548.45	52.20	4.07	2.71
Mast cell, donor1	11563-120D6	301.93	74.18	0.76	0.97
Mast cell, donor2	11565-120D8	155.42	59.14	0.59	0.89
Mast cell, donor3	11566-120D9	202.16	76.09	0.90	1.80
Mast cell, donor4	11567-120E1	184.38	85.99	0.18	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	202.05	29.05	0.44	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	256.24	19.26	1.17	1.17
Mast cell, expanded, donor5	11939-126A4	245.73	54.26	1.03	1.26
Mast cell, expanded, donor8	11941-126A6	204.02	42.68	1.51	1.17
Melanocyte - dark, donor1	11502-119F8	110.14	78.30	0.50	0.20
Melanocyte - dark, donor2	11582-120F7	113.52	55.37	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	105.55	46.00	0.22	0.07
Melanocyte - light, donor1	11274-116H5	63.94	27.74	0.47	0.24
Melanocyte - light, donor2	11351-117H1	94.86	34.12	0.00	0.68
Melanocyte - light, donor3	11423-118G1	71.98	38.16	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	57.89	44.88	0.42	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	97.09	36.04	0.81	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	79.02	38.57	0.80	0.00
Meningeal Cells, donor1	11493-119E8	235.09	126.17	0.99	0.50
Meningeal Cells, donor2	11573-120E7	189.70	144.37	1.32	0.00
Meningeal Cells, donor3	11654-122E7	142.87	46.86	0.82	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	158.26	92.39	0.57	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	32.30	15.80	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	182.67	86.73	5.26	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	214.54	104.65	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	74.63	43.77	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	100.17	26.05	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	116.61	33.17	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	210.96	92.30	0.88	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	192.14	109.59	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	194.37	97.39	0.61	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	141.42	55.13	0.83	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	135.31	41.63	1.12	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	110.13	21.84	0.66	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	97.03	28.19	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	60.72	25.69	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	214.53	83.89	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	116.61	61.32	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	97.26	35.65	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	127.00	67.49	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	53.83	42.96	1.06	0.27
Mesothelial Cells, donor2	12156-128G5	78.07	46.04	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	66.77	39.89	0.14	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	860.16	179.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	486.15	124.37	0.49	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	659.59	126.03	2.06	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	829.70	245.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	368.84	102.28	0.62	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	494.11	82.77	1.87	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	597.54	217.71	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	396.16	107.36	0.75	2.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	634.45	98.22	1.40	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	798.11	369.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	376.56	81.49	0.61	2.64
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	552.76	79.19	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	675.57	367.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	296.45	73.45	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	576.36	78.65	1.90	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	515.84	190.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	325.34	70.67	0.42	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	393.19	92.08	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	285.54	71.53	1.19	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	645.52	239.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	712.94	577.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	311.12	62.73	0.75	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	419.96	69.87	0.95	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	589.93	115.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	277.91	46.74	0.46	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	504.18	83.71	1.68	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	277.00	50.35	0.61	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	316.87	57.93	0.43	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	405.24	79.14	2.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	423.06	257.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	235.01	38.55	1.10	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	419.76	97.84	1.52	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	391.05	104.39	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	261.74	57.08	1.36	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	415.54	69.11	1.47	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	321.65	81.77	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	236.43	31.72	0.96	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	403.43	69.24	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	385.31	91.87	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	275.82	44.05	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	404.21	53.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	269.08	126.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	220.71	40.73	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	583.83	209.69	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	321.48	90.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	222.88	36.94	0.74	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	416.84	141.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	375.68	190.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	193.84	36.58	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	441.55	107.22	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	207.73	99.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	207.89	33.95	0.00	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	379.88	105.99	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	228.44	97.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	148.42	35.90	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	341.84	72.63	0.83	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	223.78	194.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	171.78	51.72	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	392.69	98.46	0.57	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	140.81	52.51	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	127.24	29.28	0.26	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	376.21	100.38	0.00	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	191.19	93.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	115.30	38.97	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	295.44	98.18	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	96.90	47.46	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	135.37	30.90	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	338.55	84.47	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	190.36	64.84	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	130.40	42.05	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	308.48	78.66	0.25	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	169.43	97.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	133.49	52.63	0.29	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	279.10	82.75	0.29	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	168.98	48.22	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	125.37	63.13	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	105.47	48.97	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	281.60	80.20	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	254.64	73.93	1.31	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	189.35	71.53	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	214.29	41.91	0.59	1.78
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	407.92	93.13	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	599.72	98.39	1.50	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	303.63	49.27	0.27	1.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	129.05	45.24	0.11	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	310.16	77.36	0.74	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	227.18	74.38	0.37	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	188.23	57.56	3.11	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	177.43	57.18	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	289.79	73.41	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	259.55	77.77	0.00	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	206.18	53.97	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	164.80	65.37	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	375.12	85.20	0.00	1.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	332.03	63.98	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	185.78	52.87	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	74.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	508.94	130.50	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	180.59	38.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	175.69	75.29	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	123.23	42.23	1.08	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	107.14	41.29	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	87.44	18.02	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	116.45	52.17	2.50	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	128.54	42.59	0.57	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	215.44	79.79	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	77.51	21.76	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	165.39	44.10	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	61.94	16.32	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	132.26	49.28	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	89.45	25.94	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	97.55	29.22	1.26	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	467.66	33.40	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	101.26	21.34	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	49.80	10.83	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	79.57	24.94	1.13	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	68.26	19.27	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	66.16	14.58	0.36	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	81.16	14.85	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	76.24	24.01	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	53.16	13.46	0.98	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	62.28	19.03	0.98	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	68.97	18.34	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	45.01	14.77	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	57.46	17.01	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	54.63	15.42	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	71.05	27.94	2.41	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	270.54	58.15	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	55.70	18.27	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	49.54	27.10	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	54.12	19.46	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	57.52	19.32	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	261.81	99.31	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	59.65	33.66	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	54.10	17.13	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	52.38	11.90	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	65.01	15.79	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	40.86	21.57	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	61.92	20.53	0.98	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	49.24	26.58	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	57.44	17.64	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	44.98	18.52	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	53.19	13.96	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	47.12	15.87	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	65.08	20.29	0.38	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	43.55	26.01	0.91	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	57.02	13.70	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	63.02	9.49	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	245.26	30.66	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	43.29	23.78	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	50.67	27.07	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	51.45	27.24	0.91	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	45.89	7.91	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	83.89	12.47	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	182.08	20.23	0.00	0.00
Myoblast, donor1	11241-116D8	156.40	39.63	0.62	0.75
Myoblast, donor2	11322-117D8	111.43	48.91	0.58	1.73
Myoblast, donor3	11398-118D3	121.58	42.71	0.50	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	210.29	104.63	2.04	0.58
Natural Killer Cells, donor1	11230-116C6	106.40	32.90	1.23	0.31
Natural Killer Cells, donor2	11311-117C6	98.61	41.31	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	116.87	48.96	0.37	0.55
Neural stem cells, donor1	11275-116H6	218.49	28.31	0.36	1.09
Neural stem cells, donor2	11352-117H2	435.20	63.55	1.93	1.93
Neurons, donor1	11494-119E9	333.40	38.69	0.00	1.14
Neurons, donor2	11574-120E8	349.62	55.70	0.66	1.32
Neurons, donor3	11655-122E8	295.16	30.42	1.64	0.82
Neutrophils, donor1	11233-116C9	114.14	113.22	3.71	0.00
Neutrophils, donor2	11314-117C9	75.37	72.47	11.60	2.90
Neutrophils, donor3	11390-118C4	132.55	132.55	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	149.73	40.61	0.12	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	128.94	31.58	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	102.48	51.14	0.60	0.60
Olfactory epithelial cells, donor1	11933-125I7	72.40	15.83	0.83	0.41
Olfactory epithelial cells, donor2	11934-125I8	113.34	24.75	0.87	0.58
Olfactory epithelial cells, donor3	11935-125I9	82.18	20.32	0.34	0.57
Olfactory epithelial cells, donor4	11936-126A1	106.36	28.44	0.29	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	113.14	54.16	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	189.30	52.75	0.21	1.06
Osteoblast - differentiated, donor2	11353-117H3	57.16	41.15	0.00	3.43
Osteoblast - differentiated, donor3	11425-118G3	52.14	30.41	0.62	0.00
Osteoblast, donor1	11277-116H8	178.63	44.56	0.00	0.20
Osteoblast, donor2	11354-117H4	170.66	58.29	0.70	0.00
Osteoblast, donor3	11426-118G4	186.62	75.89	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	212.02	59.47	1.26	0.84
Pericytes, donor1	11491-119E6	198.83	83.56	0.78	0.33
Pericytes, donor2	11571-120E5	139.21	76.06	1.36	0.23
Pericytes, donor3	11652-122E5	158.69	84.84	2.03	0.61
Perineurial Cells, donor1	11499-119F5	150.88	69.73	0.34	0.11
Perineurial Cells, donor2	11579-120F4	129.74	74.44	0.28	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	121.76	54.19	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	104.56	43.34	0.49	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	93.31	40.77	0.39	0.13
Placental Epithelial Cells, donor1	11278-116H9	59.55	28.22	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	97.58	31.05	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	75.39	35.73	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	99.68	24.05	2.22	0.32
Preadipocyte - breast, donor1	11467-119B9	79.35	17.26	1.13	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	50.12	15.14	0.65	0.13
Preadipocyte - breast, donor2	11328-117E5	104.02	34.90	0.90	0.90
Preadipocyte - omental, donor1	11468-119C1	64.79	14.39	0.32	0.43
Preadipocyte - omental, donor2	11329-117E6	144.91	40.16	1.75	0.44
Preadipocyte - omental, donor3	11403-118D8	82.80	32.37	0.86	0.14
Preadipocyte - perirenal, donor1	11469-119C2	104.33	49.21	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	153.56	54.05	0.00	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	176.72	63.57	0.18	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	191.57	60.96	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	218.71	64.92	0.37	0.47
Preadipocyte - visceral, donor2	11357-117H7	140.82	29.91	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	162.69	71.05	0.31	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	389.95	39.52	0.91	1.21
Prostate Epithelial Cells, donor2	11331-117E8	87.07	22.48	0.54	0.54
Prostate Epithelial Cells, donor3	11404-118D9	28.35	27.62	0.06	0.31
Prostate Stromal Cells, donor1	11254-116F3	117.66	35.08	0.80	0.46
Prostate Stromal Cells, donor2	11332-117E9	156.89	40.52	0.54	1.26
Prostate Stromal Cells, donor3	11405-118E1	125.13	50.37	0.63	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	162.42	62.41	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	131.28	33.41	0.55	0.69
Renal Epithelial Cells, donor1	11517-119H5	187.68	62.39	0.51	1.01
Renal Epithelial Cells, donor2	11597-120H4	207.71	73.98	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	130.11	30.17	0.21	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	166.13	121.87	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	141.10	126.68	1.35	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	139.87	62.39	1.11	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	149.06	53.90	3.99	1.33
Renal Mesangial Cells, donor1	11518-119H6	245.62	100.14	1.32	0.44
Renal Mesangial Cells, donor2	11598-120H5	176.81	52.04	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	213.88	67.41	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	204.81	81.06	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	142.95	46.39	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	190.92	77.33	0.77	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	133.27	61.19	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	138.43	47.75	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	194.50	80.27	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	80.04	15.05	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	95.02	41.96	0.67	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	75.05	21.44	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	50.63	7.71	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	90.49	22.62	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	112.08	39.66	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	88.08	29.49	0.40	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	88.56	28.55	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	106.55	46.14	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	90.79	33.80	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	105.86	35.36	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	79.27	41.07	0.14	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	86.38	27.99	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	83.86	36.20	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	82.06	43.90	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	83.06	28.65	0.32	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	95.37	33.63	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	78.96	34.99	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	88.32	33.82	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	100.15	25.56	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	101.12	52.02	0.13	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	90.72	35.92	0.29	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	90.51	32.65	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	85.11	46.67	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	87.74	24.67	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	84.77	30.93	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	90.98	45.58	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	80.45	26.73	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	91.34	37.74	0.00	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	79.72	35.15	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	86.91	25.99	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	85.82	32.97	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	87.50	43.54	0.83	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	85.83	21.24	0.22	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	83.14	36.97	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	91.38	39.97	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	98.26	40.36	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	92.54	36.05	0.00	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	86.66	34.04	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	94.92	38.41	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	92.76	27.74	0.66	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	96.29	41.59	0.34	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	99.58	36.69	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	93.56	36.78	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	81.72	44.38	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	88.34	43.57	0.71	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	105.41	43.73	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	80.61	39.08	0.09	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	88.39	26.90	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	67.39	19.64	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	91.06	36.84	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	74.67	21.11	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	93.09	34.68	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	80.47	31.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	90.93	25.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	108.13	37.44	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	83.36	28.46	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	84.31	25.83	0.00	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	108.18	36.66	0.00	3.61
Schwann Cells, donor1	11498-119F4	223.99	173.40	1.32	2.44
Schwann Cells, donor2	11578-120F3	108.88	44.23	0.00	6.80
Schwann Cells, donor3	11659-122F3	126.19	50.39	0.88	1.10
Sebocyte, donor1	11220-116B5	180.76	86.55	0.55	0.55
Sebocyte, donor2	11301-117B5	89.61	41.36	1.38	0.92
Sebocyte, donor3	11378-118B1	74.20	39.78	0.41	0.00
Sertoli Cells, donor1	11255-116F4	185.54	59.64	0.00	0.00
Sertoli Cells, donor2	11333-117F1	121.45	33.89	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	117.80	30.70	0.35	0.44
Skeletal Muscle Cells, donor2	11358-117H8	49.15	15.90	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	250.81	134.60	0.84	2.51
Skeletal Muscle Cells, donor4	11451-119A2	132.12	101.95	0.63	1.57
Skeletal Muscle Cells, donor5	11455-119A6	130.06	84.88	1.64	1.64
Skeletal Muscle Cells, donor6	11459-119B1	120.20	84.65	0.62	1.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	184.47	74.34	1.89	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	162.67	87.33	0.86	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	132.64	80.56	1.49	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	139.10	36.23	0.34	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	123.04	51.39	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	228.96	78.84	0.28	2.20
Skin - palm, donor1	10286-104F7	91.33	21.49	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	62.42	14.42	0.29	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	41.71	9.00	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	76.34	14.54	0.91	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	77.15	23.08	0.42	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	65.69	16.74	0.42	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	65.34	21.14	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	47.59	25.11	0.45	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	185.46	56.47	1.23	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	70.26	16.23	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	194.57	61.72	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	172.82	64.75	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	222.49	84.66	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	192.37	51.76	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	82.06	11.01	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	128.29	34.47	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	126.34	41.01	0.22	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	121.50	59.02	0.26	3.97
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	90.84	52.75	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	116.06	50.80	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	93.53	65.20	0.71	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	211.31	92.24	1.95	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	88.89	47.19	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	168.46	41.17	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	208.10	177.50	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	133.04	51.50	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	116.95	41.74	1.33	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	111.49	43.91	0.86	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	124.17	55.00	0.42	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	222.12	71.00	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	223.12	64.67	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	167.66	70.23	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	208.25	120.17	1.02	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	105.31	31.02	0.31	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	163.44	39.35	0.91	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	117.64	48.47	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	183.56	51.93	0.00	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	131.93	107.82	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	159.39	68.84	0.67	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	102.93	41.07	0.88	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	145.86	40.84	0.51	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	270.34	76.14	0.45	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	252.06	72.02	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	492.33	162.82	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	220.91	56.74	0.93	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	161.56	44.93	1.51	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	141.65	43.88	0.63	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	138.65	69.03	1.77	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	140.21	90.55	0.50	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	128.47	45.31	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	145.36	50.23	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	184.59	77.25	0.76	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	206.65	71.64	0.38	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	181.95	63.86	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	128.87	40.47	0.25	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	57.14	21.43	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	139.46	56.76	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	197.75	59.88	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	186.67	74.90	0.29	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	74.83	22.55	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	125.88	28.83	2.38	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	68.81	14.88	1.49	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	128.64	29.47	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	103.62	24.42	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	150.46	27.57	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	113.52	27.68	1.02	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	76.67	33.54	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	122.06	24.24	1.67	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	89.38	31.63	0.92	0.92
Synoviocyte, donor1	11291-117A4	159.06	26.93	0.50	0.67
Synoviocyte, donor2	11368-117I9	118.51	27.99	0.00	0.34
Synoviocyte, donor3	11440-118H9	82.89	22.56	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	317.31	161.87	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	126.85	47.57	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	191.49	82.20	1.39	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	67.31	36.92	0.07	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	92.78	55.67	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	75.59	38.37	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	94.73	38.88	0.37	0.25
Urethra, donor2	10319-105A4	226.60	57.55	0.00	0.00
Urothelial Cells, donor1	11520-119H8	112.64	56.05	1.59	1.06
Urothelial Cells, donor2	11600-120H7	74.51	36.85	0.80	0.00
Urothelial Cells, donor3	11681-122H7	73.12	48.59	0.23	0.46
Urothelial cells, donor0	11216-116B1	76.45	40.79	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	418.20	170.84	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	437.46	167.26	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	251.22	84.88	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	232.43	73.69	0.00	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	214.98	50.55	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	347.77	137.44	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	359.77	116.56	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	312.21	86.73	0.00	2.74
Wilms' tumor cell line:G-401	10809-111A8	98.20	75.62	1.36	0.49
Wilms' tumor cell line:HFWT	10597-108E3	115.29	179.53	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	198.87	118.71	3.35	0.28
achilles tendon, donor2	10292-104G4	90.93	39.26	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	159.86	26.01	1.27	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	403.29	36.22	2.09	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	236.35	34.90	1.19	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	281.64	78.64	3.81	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	188.61	46.66	1.41	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	125.62	40.60	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	196.54	51.72	1.09	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	154.66	47.15	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	113.93	19.19	1.63	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	286.18	81.15	1.94	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	142.97	21.71	0.74	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	175.52	35.10	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	133.15	36.25	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	322.59	57.99	2.07	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	169.79	53.48	1.46	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	244.46	50.66	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	267.31	22.21	2.88	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	332.43	115.41	7.67	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	233.84	87.05	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	267.81	89.47	2.12	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	254.43	77.03	2.17	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	167.05	25.39	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	194.12	39.36	2.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	353.06	172.81	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	180.80	85.88	1.51	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	265.17	61.93	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	537.97	271.80	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	106.45	38.86	1.18	0.71
adipose tissue, adult, pool1	10010-101C1	127.20	33.66	0.47	0.31
adipose, donor1	10184-103D4	364.75	119.04	5.28	2.35
adipose, donor2	10185-103D5	232.77	66.50	2.84	0.00
adipose, donor3	10186-103D6	281.27	91.49	1.09	1.09
adipose, donor4	10187-103D7	407.37	258.29	3.47	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	59.02	163.66	1.10	0.16
adrenal gland, adult, pool1	10081-102A9	145.51	61.84	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	148.61	36.29	1.47	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	144.35	85.75	1.43	1.43
amniotic membrane cells, donor1	12235-129G3	28.52	24.81	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	121.72	60.52	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	47.43	36.53	0.00	0.00
amygdala - adult, donor10196	10167-103B5	1771.58	184.98	7.11	7.11
amygdala, adult, donor10252	10151-102I7	1007.55	194.25	2.84	1.62
amygdala, newborn, donor10223	10360-105E9	1109.68	86.50	4.20	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	85.57	10.19	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	224.37	120.90	1.32	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	134.28	35.74	1.34	0.00
aorta, adult, pool1	10052-101G7	234.38	54.52	0.59	0.20
appendix, adult	10189-103D9	200.27	72.97	0.78	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	148.92	21.32	0.00	0.00
artery, adult	10190-103E1	252.72	46.20	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	135.31	38.10	2.03	0.43
b cell line:RPMI1788	10427-106D4	187.96	87.29	1.34	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	155.37	46.89	0.83	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	68.87	39.69	0.79	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	21.26	11.05	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	250.54	55.92	2.80	0.00
bladder, adult, pool1	10011-101C2	181.10	45.85	0.22	1.20
blood, adult, pool1	10053-101G8	296.76	108.52	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	229.50	58.23	0.86	0.86
bone marrow, adult	10192-103E3	124.17	30.37	0.67	2.02
brain, adult, donor1	10084-102B3	1238.28	232.69	4.10	3.08
brain, adult, pool1	10012-101C3	1554.00	168.60	5.01	6.46
brain, fetal, pool1	10085-102B4	1712.37	264.47	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	75.32	52.86	1.98	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	86.63	31.95	0.50	0.00
breast, adult, donor1	10080-102A8	64.40	56.19	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	54.25	27.31	0.89	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	110.08	30.61	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	80.58	30.62	6.22	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	128.55	35.83	0.73	0.24
carcinoid cell line:NCI-H1770	10703-109H1	255.30	55.48	2.35	1.41
carcinoid cell line:NCI-H727	10735-110B6	167.46	32.70	0.44	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	176.19	55.46	1.90	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	165.30	38.33	2.66	1.06
caudate nucleus - adult, donor10196	10177-103C6	1327.48	119.74	6.91	2.30
caudate nucleus, adult, donor10252	10164-103B2	1201.57	176.70	4.18	4.18
caudate nucleus, adult, donor10258	10379-105H1	1807.95	113.86	3.06	3.82
caudate nucleus, newborn, donor10223	10354-105E3	951.84	67.39	1.46	1.83
cerebellum - adult, donor10196	10173-103C2	1019.64	119.44	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	527.58	93.73	1.71	1.49
cerebellum, adult, pool1	10083-102B2	592.96	102.10	2.76	1.03
cerebellum, newborn, donor10223	10357-105E6	386.91	46.50	0.83	1.66
cerebral meninges, adult	10188-103D8	1510.06	259.70	3.03	6.56
cerebrospinal fluid, donor2	10294-104G6	301.12	58.47	2.19	0.73
cervical cancer cell line:D98-AH2	10552-107I3	53.06	16.68	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	62.64	17.73	0.17	0.00
cervix, adult, pool1	10013-101C4	210.40	59.53	0.73	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	37.06	44.17	0.42	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	71.84	69.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	103.52	46.23	2.24	0.87
choriocarcinoma cell line:SCH	10785-110H2	21.93	31.05	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	30.36	54.31	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	37.61	20.51	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	102.22	42.16	0.60	0.70
chorionic membrane cells, donor3	12240-129G8	50.55	40.11	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	341.31	49.48	6.06	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	289.30	96.05	0.96	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	251.95	98.62	4.01	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	136.87	29.53	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	149.24	31.93	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	128.89	32.37	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	114.84	42.40	2.06	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	198.34	87.05	1.04	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	138.06	87.55	2.29	1.37
clear cell carcinoma cell line:TEN	10636-108I6	49.45	12.15	0.52	0.17
colon carcinoma cell line:CACO-2	10513-107D9	295.80	67.73	2.56	0.73
colon carcinoma cell line:COLO-320	10420-106C6	114.40	20.52	0.76	0.38
colon, adult, donor1	10082-102B1	172.55	71.40	0.00	1.19
colon, adult, pool1	10014-101C5	214.68	44.42	0.47	0.71
colon, fetal, donor1	10070-101I7	190.96	62.42	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	187.92	100.84	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	116.43	22.95	2.55	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	177.19	28.83	1.06	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	195.30	33.98	2.54	0.85
corpus callosum, adult, pool1	10042-101F6	378.68	65.23	0.88	0.22
cruciate ligament, donor2	10295-104G7	132.92	48.63	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	122.79	68.22	0.00	0.00
diencephalon, adult	10193-103E4	855.32	132.71	1.44	3.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	134.32	16.76	2.07	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	52.31	9.74	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	58.98	33.94	0.48	0.24
ductus deferens, adult	10196-103E7	109.14	24.92	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	285.17	56.17	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	286.17	63.27	0.74	1.47
dura mater, adult, donor1	10041-101F5	223.56	62.60	0.17	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	143.24	19.99	0.44	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	278.28	58.03	2.72	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	41.31	29.60	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	21.49	24.52	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.01	27.17	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	48.60	51.23	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	168.60	44.58	1.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	108.38	81.01	2.72	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	79.76	46.47	2.25	0.64
epidermoid carcinoma cell line:A431	10426-106D3	120.61	59.91	2.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	157.17	48.50	0.99	0.44
epididymis, adult	10197-103E8	167.87	38.09	0.63	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	169.25	110.88	4.79	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	55.05	49.55	0.39	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	57.14	18.48	0.66	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	38.58	14.17	0.39	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	62.40	21.51	0.00	0.67
esophagus, adult, pool1	10015-101C6	98.53	36.63	0.11	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	26.93	42.46	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	159.36	33.80	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	147.29	54.71	2.10	2.10
eye - muscle medial, donor2	10299-104H2	211.33	68.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	162.80	59.62	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	185.09	56.84	0.00	0.00
eye, fetal, donor1	10054-101G9	254.49	66.36	1.02	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	54.37	23.85	0.90	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	54.84	49.86	0.95	0.00
frontal lobe, adult, pool1	10040-101F4	2077.92	246.01	2.72	4.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	155.53	81.67	2.40	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	67.11	52.58	0.91	0.27
gall bladder, adult	10198-103E9	216.32	56.50	0.72	0.72
gamma delta positive T cells, donor1	11937-126A2	107.91	64.42	1.07	1.61
gamma delta positive T cells, donor2	11938-126A3	169.57	55.28	0.37	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	16.69	7.60	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	98.45	61.31	2.51	0.19
gastric cancer cell line:AZ521	10549-107H9	86.24	84.76	1.15	0.16
gastric cancer cell line:GSS	10560-108A2	67.73	25.63	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	201.50	50.49	1.37	1.37
giant cell carcinoma cell line:LU65	10487-107B1	11.36	9.41	0.46	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	76.84	83.28	1.26	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	95.78	24.69	1.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	74.63	14.88	0.84	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	74.01	18.82	1.12	0.00
glioblastoma cell line:T98G	10485-107A8	85.87	37.31	1.21	0.22
glioma cell line:GI-1	10413-106B8	91.96	33.97	0.88	0.29
globus pallidus - adult, donor10196	10175-103C4	878.34	111.52	2.19	0.73
globus pallidus, adult, donor10252	10161-103A8	337.09	83.97	0.49	0.73
globus pallidus, adult, donor10258	10367-105F7	690.08	84.89	2.74	4.11
globus pallidus, newborn, donor10223	10364-105F4	516.93	54.89	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	237.37	232.48	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	163.93	32.79	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	151.57	41.81	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	75.84	28.48	0.32	0.96
hIPS +CCl2, biol_rep1	14383-156B9	224.05	56.01	2.30	0.46
hIPS +CCl2, biol_rep2	14384-156C1	228.17	48.01	0.00	2.29
hIPS +CCl2, biol_rep3	14385-156C2	200.31	49.60	0.00	0.00
hIPS, biol_rep1	14380-156B6	237.15	30.18	0.00	1.44
hIPS, biol_rep2	14381-156B7	180.38	47.32	2.06	0.00
hIPS, biol_rep3	14382-156B8	977.67	88.28	2.21	2.21
hairy cell leukemia cell line:Mo	10712-109I1	140.80	50.29	0.00	0.86
heart - mitral valve, adult	10205-103F7	160.55	28.10	0.30	0.90
heart - pulmonic valve, adult	10206-103F8	266.70	35.30	0.00	1.31
heart - tricuspid valve, adult	10207-103F9	88.26	41.63	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	177.73	88.36	2.04	0.61
heart, adult, diseased, donor1	10051-101G6	267.85	54.08	0.43	0.43
heart, adult, pool1	10016-101C7	229.52	55.65	0.00	0.92
heart, fetal, pool1	10046-101G1	393.78	57.60	0.82	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	140.38	40.11	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	328.21	117.73	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	317.12	54.58	0.66	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	338.39	67.61	0.97	1.82
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	350.96	61.74	0.40	0.61
hepatoma cell line:Li-7	10484-107A7	98.76	16.90	1.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	175.07	76.68	0.60	0.40
hippocampus - adult, donor10196	10169-103B7	1611.60	267.81	2.84	3.79
hippocampus, adult, donor10252	10153-102I9	725.58	164.50	3.27	2.45
hippocampus, adult, donor10258	10374-105G5	1810.55	92.12	5.48	2.49
hippocampus, newborn, donor10223	10363-105F3	1232.61	138.88	2.82	3.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	203.85	57.98	2.44	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	152.96	64.60	0.98	1.96
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	158.68	48.24	1.27	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	223.29	67.10	2.82	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	277.32	76.69	2.58	5.42
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	285.47	66.81	2.66	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	332.54	51.09	6.71	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	335.85	75.62	2.37	1.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	328.24	47.96	5.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	336.96	65.12	2.84	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	363.06	68.47	2.57	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	333.28	58.58	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	141.31	50.39	1.10	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	145.91	48.64	2.95	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	132.66	38.40	2.62	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	281.78	72.36	2.67	3.25
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	245.95	80.24	3.92	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	229.39	42.98	2.50	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	258.85	46.91	3.01	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	271.92	38.65	4.09	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	259.05	33.20	4.07	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	320.07	40.34	2.29	2.78
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	324.28	47.61	1.16	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	291.75	35.57	0.90	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	185.30	54.13	1.66	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	168.89	64.76	1.71	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	217.63	49.81	1.63	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	265.82	74.99	3.52	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	224.89	66.83	2.22	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	244.52	53.87	3.63	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	315.96	45.51	1.03	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	313.49	45.83	4.65	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	288.60	28.99	1.03	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	284.28	38.09	1.79	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	328.63	42.40	0.76	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	245.66	26.88	3.70	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	182.34	52.89	1.69	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	153.75	33.87	1.78	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	181.95	45.85	2.44	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	252.44	62.04	2.14	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	689.69	104.10	6.51	35.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	265.75	54.27	3.31	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	344.25	50.90	2.19	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	296.38	36.91	2.90	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	279.36	28.83	3.20	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	295.96	29.83	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	394.36	51.06	2.03	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	237.88	26.94	1.89	0.54
immature langerhans cells, donor1	11904-125F5	53.51	30.75	0.00	0.24
immature langerhans cells, donor2	11905-125F6	38.81	29.31	0.79	0.79
insula, adult, pool1	10039-101F3	2394.42	263.18	3.60	2.27
keratoacanthoma cell line:HKA-1	10791-110H8	44.22	13.98	0.33	0.33
kidney, adult, pool1	10017-101C8	158.80	33.44	0.50	0.60
kidney, fetal, pool1	10045-101F9	192.90	51.71	0.42	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	135.49	78.68	1.70	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.97	4.70	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	74.32	23.30	1.47	0.37
left atrium, adult, donor1	10079-102A7	135.67	64.84	0.00	1.09
left ventricle, adult, donor1	10078-102A6	226.53	50.06	3.54	0.00
leiomyoblastoma cell line:G-402	10721-110A1	85.09	134.89	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	176.03	44.19	1.44	1.08
leiomyoma cell line:15242A	10570-108B3	119.02	34.78	1.09	0.54
leiomyoma cell line:15425	10571-108B4	177.26	44.19	1.70	3.89
leiomyosarcoma cell line:Hs 5.T	10722-110A2	139.69	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	96.19	12.55	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	294.20	106.49	2.13	0.94
liposarcoma cell line:KMLS-1	10782-110G8	90.60	30.93	1.09	0.47
liposarcoma cell line:SW 872	10726-110A6	250.01	54.10	1.10	0.24
liver, adult, pool1	10018-101C9	75.52	25.44	0.32	0.32
liver, fetal, pool1	10086-102B5	93.13	43.27	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	713.96	114.33	2.04	0.87
locus coeruleus, adult, donor10252	10165-103B3	464.51	105.38	1.85	0.74
locus coeruleus, adult, donor10258	10375-105G6	571.89	86.33	4.80	4.80
locus coeruleus, newborn, donor10223	10362-105F2	517.36	31.97	1.68	0.84
lung adenocarcinoma cell line:A549	10499-107C4	39.58	34.18	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	73.08	35.85	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	62.22	37.30	0.92	0.26
lung, adult, pool1	10019-101D1	87.41	49.61	0.59	0.35
lung, fetal, donor1	10068-101I5	195.79	71.92	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	87.52	54.99	0.46	0.00
lymph node, adult, donor1	10077-102A5	92.78	59.64	0.00	1.42
lymphangiectasia cell line:DS-1	10727-110A7	21.48	39.45	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	174.62	24.15	0.60	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	73.91	31.43	0.00	0.85
mature adipocyte, donor1	12231-129F8	40.85	43.51	0.44	0.44
mature adipocyte, donor2	12232-129F9	43.17	40.88	0.42	0.00
mature adipocyte, donor3	12233-129G1	27.74	28.68	0.00	0.24
mature adipocyte, donor4	12234-129G2	31.06	28.69	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	34.07	25.26	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	1875.91	205.30	6.77	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	1146.29	176.37	5.15	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	1466.45	179.49	4.13	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	2056.10	120.27	7.68	18.77
medial temporal gyrus - adult, donor10196	10183-103D3	1750.45	164.19	8.44	6.75
medial temporal gyrus, adult, donor10252	10156-103A3	1122.24	152.59	0.85	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1806.83	84.76	5.78	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	2224.81	258.37	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	1938.23	120.60	3.95	2.51
medulla oblongata - adult, donor10196	10174-103C3	303.72	54.51	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	321.68	69.66	0.77	0.77
medulla oblongata, adult, pool1	10038-101F2	661.51	114.36	1.31	0.65
medulla oblongata, newborn, donor10223	10361-105F1	370.79	39.58	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	106.28	35.65	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	51.60	21.28	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	68.42	19.84	0.72	0.00
melanoma cell line:G-361	10465-106H6	34.75	10.04	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	49.75	15.92	0.72	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	415.02	42.30	12.34	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	274.26	60.66	2.07	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	171.23	87.15	2.61	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	122.52	50.17	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	148.66	47.21	3.73	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	107.60	39.75	0.84	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	107.07	48.53	1.35	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	172.83	46.50	3.47	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	54.58	38.45	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	119.73	53.60	0.58	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	133.30	65.66	1.33	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	126.67	65.90	0.95	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	85.22	46.95	1.56	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.70	16.47	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	113.74	62.54	0.97	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	168.61	63.88	0.35	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	77.99	33.28	0.61	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.49	10.42	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	77.28	35.48	0.31	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	54.72	25.08	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	147.26	40.70	2.94	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	62.61	32.28	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	91.56	45.17	1.14	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	54.86	20.25	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	61.52	22.89	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	169.67	30.73	1.26	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	206.87	79.00	3.65	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	199.77	52.44	2.81	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	203.91	56.02	3.14	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	203.03	47.75	1.54	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	196.76	47.54	1.41	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	202.06	47.05	2.03	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	214.96	47.94	1.18	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	189.52	42.17	1.85	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	220.35	63.16	2.31	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	208.60	57.78	1.78	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	216.56	57.68	1.44	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	186.27	60.87	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	197.03	53.03	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	198.96	57.72	2.05	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	199.74	49.40	0.86	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	232.42	35.55	0.00	8.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	180.77	25.82	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	210.46	52.94	1.62	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	165.87	49.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	232.96	61.30	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	179.09	53.16	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	209.91	52.48	1.17	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	176.29	33.58	6.30	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	181.80	35.76	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	209.76	52.44	9.53	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	183.82	52.18	3.56	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	220.54	41.43	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	208.38	44.97	2.53	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	114.51	34.84	0.34	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	118.21	23.64	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	139.71	27.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	13.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	54.19	22.41	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	65.94	14.30	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	48.93	13.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	52.05	17.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	52.13	17.38	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	42.58	29.57	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	56.50	10.27	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	61.96	23.41	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	31.17	31.17	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	33.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	33.71	24.81	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	45.13	41.91	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	50.15	65.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	55.75	44.35	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.21	32.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	18.08	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.89	33.77	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	57.74	21.03	0.60	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	63.60	31.48	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	55.01	32.60	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	119.15	43.33	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	41.34	77.96	1.89	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	92.67	50.50	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	213.68	59.83	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	266.64	48.91	1.64	2.26
mesothelioma cell line:Mero-25	10850-111F4	40.17	12.94	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	84.34	27.63	0.24	0.73
mesothelioma cell line:Mero-48a	10852-111F6	113.15	37.42	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	120.36	25.49	1.31	0.79
mesothelioma cell line:Mero-83	10854-111F8	147.41	27.24	0.34	1.19
mesothelioma cell line:Mero-84	10855-111F9	114.25	80.38	2.27	0.76
mesothelioma cell line:Mero-95	10856-111G1	84.27	20.50	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	109.82	25.18	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	122.53	42.53	0.90	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	77.04	20.84	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	68.96	22.65	0.76	0.25
mesothelioma cell line:No36	10857-111G2	98.19	28.38	0.98	0.65
mesothelioma cell line:ONE58	10858-111G3	95.65	17.88	0.81	0.81
migratory langerhans cells, donor1	11901-125F2	171.96	48.75	0.96	1.73
migratory langerhans cells, donor2	11902-125F3	115.40	55.07	0.61	0.98
migratory langerhans cells, donor3	11903-125F4	197.07	73.77	0.54	1.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	44.73	35.91	2.29	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	107.66	74.81	0.85	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	76.71	34.32	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	233.11	99.90	0.00	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	70.41	26.43	0.92	0.55
myeloma cell line:PCM6	10474-106I6	88.16	26.09	0.99	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	268.36	107.04	2.03	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.67	20.20	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.75	27.86	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.92	24.42	0.22	0.37
nasal epithelial cells, donor2	12227-129F4	133.03	83.35	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	107.67	16.79	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	230.86	51.26	1.50	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	133.07	26.57	1.05	0.42
neuroblastoma cell line:NH-12	10555-107I6	118.89	25.53	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	118.14	16.84	0.95	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	55.27	30.57	0.48	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	58.57	41.46	0.81	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	102.36	91.55	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	170.61	54.03	1.33	0.27
neutrophil PMN, donor1	12133-128D9	14.87	282.62	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	338.58	28.41	2.20	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	284.98	29.62	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	168.00	56.43	1.92	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	106.68	24.17	0.79	1.58
nucleus accumbens, adult, pool1	10037-101F1	2001.61	230.69	2.62	2.34
occipital cortex - adult, donor10196	10172-103C1	1841.98	218.40	8.24	2.06
occipital cortex, adult, donor10252	10163-103B1	759.74	132.03	2.15	1.61
occipital cortex, newborn, donor10223	10355-105E4	2008.24	108.82	3.28	3.64
occipital lobe, adult, donor1	10076-102A4	1818.95	301.76	7.61	21.78
occipital lobe, fetal, donor1	10073-102A1	1025.55	178.51	5.58	3.86
occipital pole, adult, pool1	10036-101E9	2086.86	238.02	3.00	3.00
olfactory region, adult	10195-103E6	1469.76	188.19	5.16	4.39
optic nerve, donor1	10277-104E7	382.20	78.04	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.20	30.64	0.46	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	75.97	35.45	0.41	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	60.45	18.63	0.51	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	38.58	21.60	0.23	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	101.12	34.39	0.88	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	51.39	39.24	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	50.68	25.66	0.85	0.21
ovary, adult, pool1	10020-101D2	195.75	61.76	0.61	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	92.03	35.75	0.92	0.37
pancreas, adult, donor1	10049-101G4	137.33	58.32	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	41.93	46.40	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	155.70	37.65	2.38	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	59.28	35.27	0.83	0.00
paracentral gyrus, adult, pool1	10035-101E8	1950.52	281.34	2.93	2.65
parietal cortex, adult, donor10258	10373-105G4	1335.16	157.08	4.40	2.20
parietal lobe - adult, donor10196	10171-103B9	1434.24	167.41	6.58	4.70
parietal lobe, adult, donor10252	10157-103A4	1101.38	169.60	3.99	3.99
parietal lobe, adult, pool1	10034-101E7	1889.20	281.28	2.64	2.56
parietal lobe, fetal, donor1	10072-101I9	1007.66	164.87	6.79	1.94
parietal lobe, newborn, donor10223	10356-105E5	1915.66	105.43	5.23	4.86
parotid gland, adult	10199-103F1	50.57	16.03	0.00	0.62
penis, adult	10200-103F2	177.78	39.21	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	28.26	8.92	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	45.02	28.26	0.73	0.15
pineal gland - adult, donor10196	10179-103C8	352.83	23.22	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	267.09	28.43	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	325.45	24.46	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	153.79	27.32	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	150.62	38.57	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	138.75	18.73	0.85	0.00
placenta, adult, pool1	10021-101D3	72.78	42.36	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	137.72	58.14	1.46	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	99.30	22.72	1.25	0.31
pons, adult, pool1	10033-101E6	1248.58	189.09	1.81	2.24
postcentral gyrus, adult, pool1	10032-101E5	2077.22	280.01	3.66	3.84
promyelocytes/myelocytes PMC, donor1	12132-128D8	336.71	125.48	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	176.26	27.54	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	187.77	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	75.74	53.60	0.58	0.58
prostate cancer cell line:PC-3	10439-106E7	104.36	40.66	2.90	0.54
prostate, adult, pool1	10022-101D4	194.26	56.32	0.45	0.45
putamen, adult, donor10196	10176-103C5	2430.98	246.45	4.01	6.85
putamen, adult, donor10252	10152-102I8	813.70	170.58	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	959.49	41.53	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	1601.16	126.36	6.04	2.42
putamen, newborn, donor10223	10365-105F5	614.72	22.49	3.75	3.00
rectal cancer cell line:TT1TKB	10469-106I1	80.30	30.55	0.29	0.58
rectum, fetal, donor1	10067-101I4	374.18	166.92	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	156.45	70.60	4.66	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	101.07	32.72	3.73	0.00
retina, adult, pool1	10030-101E3	284.28	53.38	0.00	0.70
retinoblastoma cell line:Y79	10475-106I7	140.29	43.91	1.04	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	140.90	100.94	1.35	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	132.45	68.05	1.12	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	193.25	84.12	2.27	0.00
salivary acinar cells, donor1	11771-123I7	42.41	23.47	0.32	0.32
salivary acinar cells, donor2	11772-123I8	53.15	18.73	0.41	0.00
salivary acinar cells, donor3	11773-123I9	49.65	25.82	0.66	0.00
salivary gland, adult, pool1	10093-102C3	53.76	28.03	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	33.72	11.13	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.39	12.70	0.59	0.12
seminal vesicle, adult	10201-103F3	134.91	20.10	2.12	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	39.11	13.85	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	58.38	16.10	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	108.38	27.10	3.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	97.25	22.83	0.40	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	57.14	14.04	0.77	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	197.92	29.29	1.55	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	233.37	61.00	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	140.93	56.13	0.60	0.48
skeletal muscle, fetal, donor1	10066-101I3	104.52	47.24	0.00	0.00
skin, adult, donor1	10074-102A2	74.64	40.71	0.00	0.00
skin, fetal, donor1	10065-101I2	178.01	77.64	0.00	5.68
small cell cervical cancer cell line:HCSC-1	10800-110I8	469.27	211.12	2.33	2.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	211.50	41.61	1.58	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	38.94	72.28	0.58	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	48.62	16.15	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	78.49	26.38	0.64	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	168.23	23.10	0.44	0.22
small intestine, adult, pool1	10024-101D6	431.79	52.91	0.36	1.79
small intestine, fetal, donor1	10064-101I1	330.71	49.14	0.74	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	179.52	44.62	4.10	2.56
smooth muscle, adult, pool1	10048-101G3	207.80	72.37	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	114.44	22.51	1.34	0.00
spinal cord - adult, donor10196	10181-103D1	468.22	69.05	1.84	1.15
spinal cord, adult, donor10252	10159-103A6	191.22	44.16	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	286.40	38.05	1.38	1.38
spinal cord, fetal, donor1	10056-101H2	887.31	168.92	5.49	4.27
spinal cord, newborn, donor10223	10359-105E8	325.58	34.90	2.30	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	140.54	42.42	1.34	0.45
spleen, adult, pool1	10025-101D7	69.83	47.80	0.66	0.33
spleen, fetal, pool1	10044-101F8	116.24	53.00	0.16	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	124.94	35.50	0.93	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	55.44	36.08	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	185.56	88.06	4.89	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	37.53	32.84	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	33.20	15.98	0.79	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	60.58	28.38	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	148.92	69.38	2.96	0.00
stomach, fetal, donor1	10062-101H8	208.25	86.51	0.00	0.00
submaxillary gland, adult	10202-103F4	59.25	22.79	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	542.74	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	147.26	34.48	0.00	0.62
substantia nigra, adult, donor10258	10371-105G2	882.43	87.42	2.59	1.03
substantia nigra, newborn, donor10223	10358-105E7	362.47	23.32	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	146.27	64.19	1.38	0.23
temporal lobe, adult, pool1	10031-101E4	2242.60	266.01	4.49	5.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1307.01	198.72	4.99	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	1148.95	98.90	3.96	10.11
tenocyte, donor1	11763-123H8	223.08	57.25	2.09	0.70
tenocyte, donor2	11765-123I1	121.32	42.35	0.00	0.38
tenocyte, donor3	11768-123I4	194.23	45.96	0.74	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	105.72	92.29	2.21	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	131.95	68.90	1.54	0.77
teratocarcinoma cell line:PA-1	10807-111A6	144.13	129.87	2.17	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	119.58	128.98	1.90	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	33.28	24.20	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	52.46	33.26	0.65	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	101.62	94.13	3.91	3.26
testis, adult, pool1	10026-101D8	281.42	75.38	0.75	1.83
testis, adult, pool2	10096-102C6	727.15	169.61	2.26	2.26
thalamus - adult, donor10196	10168-103B6	804.81	96.05	4.42	4.42
thalamus, adult, donor10252	10154-103A1	348.67	51.89	0.94	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	1516.52	97.00	6.16	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	662.38	99.47	5.60	2.47
thalamus, newborn, donor10223	10366-105F6	1074.70	75.37	4.60	2.30
throat, adult	10209-103G2	113.10	26.96	0.25	3.00
throat, fetal, donor1	10061-101H7	193.49	72.52	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	75.12	14.11	0.40	0.40
thymus, adult, pool1	10027-101D9	337.71	91.66	0.50	0.89
thymus, fetal, pool1	10043-101F7	207.19	64.63	0.21	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	89.88	16.22	1.06	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	125.02	65.38	0.70	0.14
thyroid, adult, pool1	10028-101E1	131.38	52.72	0.19	0.37
thyroid, fetal, donor1	10060-101H6	222.80	91.23	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	110.87	21.56	0.00	0.00
tongue, adult	10203-103F5	93.96	20.47	0.47	0.93
tongue, fetal, donor1	10059-101H5	104.83	44.53	0.00	0.00
tonsil, adult, pool1	10047-101G2	123.22	44.88	0.10	0.40
trachea, adult, pool1	10029-101E2	91.70	37.30	0.16	0.08
trachea, fetal, donor1	10058-101H4	132.33	43.86	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	208.67	58.10	1.77	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	133.43	40.83	0.51	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	33.06	28.36	0.78	0.31
tridermal teratoma cell line:HGRT	10694-109G1	258.74	135.08	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	41.14	24.38	0.42	0.17
umbilical cord, fetal, donor1	10057-101H3	179.44	50.08	0.00	0.00
uterus, adult, pool1	10100-102D1	203.90	57.16	0.17	0.17
uterus, fetal, donor1	10055-101H1	220.64	66.55	0.00	0.51
vagina, adult	10204-103F6	102.75	60.10	0.00	0.65
vein, adult	10191-103E2	156.07	42.74	0.88	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	126.04	65.96	0.00	1.07